electroCore, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from electroCore, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Cash Locked Ratio: Money owed to suppliers is larger than money owed by customers plus stock: $2 per $100 of sales comes from others' credit, against $1 tied up three years earlier. Less money tied up than 91% of Healthcare companies in United States.
- Steadiness Ratio: Sales grew in 3 of the last 3 years; profit grew in 2 of 3. Steadier than 85% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
−$2Money owed to suppliers is larger than money owed by customers plus stock: $2 per $100 of sales comes from others' credit, against $1 tied up three years earlier.
Less money tied up than 91% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Steadier than 85% of Healthcare companies in United States.
Growth Efficiency Ratio
$35Sales grew 273% in 3 years; of every extra $100 of sales, $35 became extra profit.
Higher than 61% of Healthcare companies in United States.
Asset Productivity Ratio
+273% / -25%In 3 years sales changed by +273% while total assets changed by -25%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
-21.8×Operating cash was negative last year, while some debt falls due within a year.
Lower than 56% of Healthcare companies in United States.
Cash Cushion Ratio
+3%Cash, after subtracting all debt, equals 3% of its market value (net cash).
Lower than 61% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (11)
electroCore, Inc. made a loss over the last year. electroCore, Inc. owes $1.16 for every $1 it owns. electroCore, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LosselectroCore, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
-22.78electroCore, Inc.'s book value is negative (it owes more than it owns), so P/B is not meaningful.
Market cap
$64 MThe total market value of all of electroCore, Inc.'s shares at today's price (share price × number of shares), smaller than 71% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
NegativeelectroCore, Inc.'s net worth is negative ($3 M below zero, balance sheet 30 Jun 2026): it owes more than it owns, so book value per share and P/B are not meaningful.
Owes vs Owns
1.16×electroCore, Inc. owes $1.16 for every $1 it owns, so it owes more than it owns, higher than 91% of Healthcare companies in United States.
Dividend yield
NoneelectroCore, Inc. does not currently pay a dividend.
Revenue growth
+27%Revenue rose 27% in the year to Dec 2025, and grew 55% a year on average over 3 years.
Profit growth
LosselectroCore, Inc. made a loss in each of the last two years.
Profit margin
-43.6%electroCore, Inc. lost $44 for every $100 of revenue.
Interest cover
Not coveredelectroCore, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net cashelectroCore, Inc. held $2 M more cash than debt (net cash) at Dec 2025.
Questions
How much does electroCore, Inc. owe compared with what it owns?
electroCore, Inc. owes $1.16 for every $1 it owns, so it owes more than it owns, higher than 91% of Healthcare companies in United States.
Does electroCore, Inc. pay a dividend?
No. electroCore, Inc. does not currently pay a dividend.
Is electroCore, Inc.'s revenue growing?
Revenue rose 27% in the year to Dec 2025, and grew 55% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.